Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort

Archive ouverte

Fortner, Renée Turzanski | Hüsing, Anika | Dossus, Laure | Tjønneland, Anne | Overvad, Kim | Dahm, Christina C. | Arveux, Patrick | Fournier, Agnès | Kvaskoff, Marina | Schulze, Matthias B. | Bergmann, Manuela M. | Trichopoulou, Antonia D. | Karakatsani, Anna | La Vecchia, Carlo | Masala, Giovanna | Pala, Valeria | Mattiello, Amalia | Tumino, Rosario | Ricceri, Fulvio | van Gils, Carla Henrica | Monninkhof, Evelyn M. | Bonet, Catalina | Quirós, Josè Ramón | Sanchez, María José | Rodríguez-Palacios, Daniel Ángel | Gurrea, Aurelio Barricarte | Amiano, Pilar | Allen, Naomi E. | Travis, Ruth C. | Gunter, Marc J.R. | Viallon, Vivian | Weiderpass, Elisabete | Riboli, Elio | Kaaks, Rudolf J.

Edité par CCSD ; Wiley -

International audience. Endometrial cancer (EC) incidence rates vary ~10-fold worldwide, in part due to variation in EC risk factor profiles. Using an EC risk model previously developed in the European EPIC cohort, we evaluated the prevention potential of modified EC risk factor patterns and whether differences in EC incidence between a European population and low-risk countries can be explained by differences in these patterns. Predicted EC incidence rates were estimated over 10 years of follow-up for the cohort before and after modifying risk factor profiles. Risk factors considered were: body mass index (BMI, kg/m2), use of postmenopausal hormone therapy (HT) and oral contraceptives (OC) (potentially modifiable); and, parity, ages at first birth, menarche and menopause (environmentally conditioned, but not readily modifiable). Modeled alterations in BMI (to all ≤23 kg/m2) and HT use (to all non-HT users) profiles resulted in a 30% reduction in predicted EC incidence rates; individually, longer duration of OC use (to all ≥10 years) resulted in a 42.5% reduction. Modeled changes in not readily modifiable exposures (i.e., those not contributing to prevention potential) resulted in ≤24.6% reduction in predicted EC incidence. Women in the lowest decile of a risk score based on the evaluated exposures had risk similar to a low risk countries; however, this was driven by relatively long use of OCs (median = 23 years). Our findings support avoidance of overweight BMI and of HT use as prevention strategies for EC in a European population; OC use must be considered in the context of benefits and risks.

Suggestions

Du même auteur

Predicted basal metabolic rate and cancer risk in the European Prospective Investigation into Cancer and Nutrition

Archive ouverte | Kliemann, Nathalie | CCSD

International audience. Emerging evidence suggests that a metabolic profile associated with obesity may be a more relevant risk factor for some cancers than adiposity per se. Basal metabolic rate (BMR) is an indicat...

Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women: Results from the EPIC Cohort

Archive ouverte | Sarink, Danja | CCSD

International audience. Abstract Background: Except for a documented increase in osteoprotegerin (OPG) concentrations with older age, data on determinants of soluble Receptor Activator of Nuclear Factor κB (sRANKL) ...

Tumor‐associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

Archive ouverte | Kaaks, Rudolf | CCSD

International audience. Immuno‐proteomic screening has identified several tumor‐associated autoantibodies (AAb) that may have diagnostic capacity for invasive epithelial ovarian cancer, with AAbs to P53 proteins and...

Chargement des enrichissements...